Reaction

Pneumonia Lipoid reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 130 reports · 2 co-occurring drugs

As of the last recalculation, Pneumonia Lipoid appears in 130 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 160.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Canakinumab	10	160.2	160.4
Anakinra	13	139.3	139.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.